Wolfs Pharma SRL
1.5 FTEThe score of Wolfs Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wolfs Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 30,540 € |
| Equity | 40,540 € |
| Cash | 65,828 € |
| EBITDA | 76,434 € |
| Total assets | 509,540 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jun 2026
Wolfs Pharma's financial analysis
- Solvency8.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wolfs Pharma
Wolfs Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1017.566.820
- VAT number
- BE1017566820
- Peppol
- Registered · 0208:1017566820 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Dec 2024
- Registered office
- 4020 Liège
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 01 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Wolfs Pharma (SRL) has been based in Liège since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 30,540 € and equity of 40,540 €; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 8.0%, below the median of its sector (41.5%).
Companies similar to Wolfs Pharma
Companies in the same business, of comparable size and area, outside its group.
- Saussure Pharma Retail sale of pharmaceutical products Beauraing · balance sheet 509,667 €
- Apotheek Bresseleers-Van der Cruyce Retail sale of pharmaceutical products Buggenhout · balance sheet 509,818 €
- Pharmacie Huart Retail sale of pharmaceutical products Durbuy · balance sheet 509,185 €
- Onco-HEM Retail sale of pharmaceutical products Binche · balance sheet 511,591 €
- Apoteek Diependale Retail sale of pharmaceutical products Oudenaarde · balance sheet 504,088 €
- Almapharma Retail sale of pharmaceutical products De Panne · balance sheet 515,565 €
- Curepharma Retail sale of pharmaceutical products Antwerp · balance sheet 516,103 €
- Flowers Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 516,128 €
Frequently asked questions about Wolfs Pharma
What is the revenue of Wolfs Pharma?
Wolfs Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wolfs Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1017566820 for Wolfs Pharma, if the company is VAT-registered. Its company number (CBE) is 1017.566.820.
Where is the registered office of Wolfs Pharma?
According to the CBE register, the registered office of Wolfs Pharma is in 4020 Liège.
What is the equity of Wolfs Pharma?
At the close of the 2025 financial year, the equity of Wolfs Pharma amounts to 40,540 €, a solvency of 8.0% of total assets.
How many people work at Wolfs Pharma?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Wolfs Pharma?
The register lists 1 active mandates at Wolfs Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Wolfs Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →